Conference Details - Overview

Back to Conferences

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

Seventh International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

Jumeirah Essex House
New York, NY
March 26-27, 2010

Conference Overview

Summary and Purpose

The Seventh International Symposium on Ovarian Cancer and Other Gynecologic Malignancies has been designed to provide participants with cutting-edge information on the treatment of these diseases. This symposium will focus on clinical and translational research in ovarian, uterine, cervical, and endometrial cancers, not only discussing standards of care and current guidelines but also highlighting the most promising novel chemotherapeutics and targeted agents currently undergoing clinical trial evaluation. Controversies in the management of ovarian, cervical, and endometrial cancers and uterine sarcoma will be debated. The symposium format will also include didactic lectures to present translational and clinical research topics, such as the use of investigational agents; case-based discussions to bring out key management issues and practice points; and panel discussions at the end of each session to provide participants with ample opportunities to learn from and interact with key opinion leaders in the field.

Target Audience

This educational program is directed toward medical, gynecologic, surgical, and radiation oncologists. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of gynecologic malignancies are also invited to attend.

Learning Objectives

At the conclusion of this symposium, you should be able to:

  • Apply the current standard of care to the management of ovarian cancer
  • Assess current data supporting the use of multimodality therapy in endometrial and cervical cancer
  • Describe the current chemotherapeutic and surgical options for the management of metastatic ovarian cancer
  • Outline the potential of targeted therapies for the treatment of gynecologic cancers
  • Identify optimal chemotherapeutic options for the management of advanced uterine cancers
  • Evaluate advances in supportive care for patients with gynecologic malignancies

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  3. Lilly USA, LLC
  5. sanofi-aventis U.S.